Common polygenic variation contributes to risk of schizophrenia and bipolar disorder - PubMed (original) (raw)
. 2009 Aug 6;460(7256):748-52.
doi: 10.1038/nature08185. Epub 2009 Jul 1.
Collaborators
- PMID: 19571811
- PMCID: PMC3912837
- DOI: 10.1038/nature08185
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
International Schizophrenia Consortium et al. Nature. 2009.
Abstract
Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%. We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.
Figures
Figure 1. Association results across the MHC region
Results are shown as –log10 (P-value) for genotyped SNPs. The most associated SNP is shown as a blue diamond. The colour of the remaining markers reflects r2 with rs3130375, light pink,r2 > 0.1, red,r2 > 0.8. The recombination rate from the CEU HapMap (second Y-axis) is plotted in light blue.
Figure 2. Replication of the ISC-derived polygenic component in independent SCZ and BPD samples
Variance explained in the target samples based on scores derived in the entire ISC for five significance thresholds (pT < 0.1, 0.2, 0.3, 0.4 and 0.5, plotted left to right in each study). The y-axis indicates Nagelkerke’s pseudo-R2; the number above each set of bars is the P-value for the pT < 0.5 target sample analysis. Numbers for cases/controls: MGS-EA 2687 / 2656; MGS-AA 1287 / 973; O’Donovan 479 / 2938; STEP-BD 955 / 1498; WTCCC 1829 / 2935; CAD 1926 / 2935; CD 1748 / 2935; HT 1952 / 2935; RA 1860 / 2935 ; T1D 1963 / 2935 ; T2D 1924 / 2935.
Figure 3. Observed and simulated profiles of target sample variance explained
Panel A shows the observed variance explained (R2, black line). Panel B shows a subset of models that produced results consistent with the observed data. All yielded similar estimates of the total variance explained by the SNPs that tag the causal variants, VM, with a mean value of 34%. The seven models were: (% SNPs, Mean GRR/variance explained (V) per causal allele, LD, frequency model) M1: 6.25%, GRR=1.05,r2 =1, empirical; M2: 25%, GRR=1.025, r2 =1, empirical; M3: 12%, GRR=1.05, r2<1, uniform; M4: 32%, GRR=1.04,r2 <1, U-shaped; M5: 11%, V=0.00006, r2 =1, empirical; M6: 25%, GRR(Exponential)=1.025,r2 <1, uniform; M7: 100%, GRR(Exponential)=1.012, r2 <1, uniform. Panel C shows four inconsistent models with fewer variants of larger effect.
Figure 4. Analysis stratified by score allele frequency
Panel A shows the observed data for the ISC/MGS-EA comparison. The y-axis is the target sample pseudo R2, scaled within each figure as a proportion of the maximum value observed. The two other plots show results for simulated data: the common variant model, with a uniform frequency distribution for causal risk-increasing alleles (panel B) and a multiple rare variant (MRV) model, in which the collective frequency of rare variants at a locus that all reside on the same haplotypic background with respect to the genotyped SNP was bounded at a maximum of 5% (panel C).
Comment in
- Pamela Sklar (1959-2017).
Daly M. Daly M. Nature. 2018 Feb 1;554(7690):32. doi: 10.1038/d41586-018-01382-x. Nature. 2018. PMID: 29388987 No abstract available.
Similar articles
- Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.
Allardyce J, Leonenko G, Hamshere M, Pardiñas AF, Forty L, Knott S, Gordon-Smith K, Porteous DJ, Haywood C, Di Florio A, Jones L, McIntosh AM, Owen MJ, Holmans P, Walters JTR, Craddock N, Jones I, O'Donovan MC, Escott-Price V. Allardyce J, et al. JAMA Psychiatry. 2018 Jan 1;75(1):28-35. doi: 10.1001/jamapsychiatry.2017.3485. JAMA Psychiatry. 2018. PMID: 29167880 Free PMC article. - Genome-wide association study reveals greater polygenic loading for schizophrenia in cases with a family history of illness.
Bigdeli TB, Ripke S, Bacanu SA, Lee SH, Wray NR, Gejman PV, Rietschel M, Cichon S, St Clair D, Corvin A, Kirov G, McQuillin A, Gurling H, Rujescu D, Andreassen OA, Werge T, Blackwood DH, Pato CN, Pato MT, Malhotra AK, O'Donovan MC, Kendler KS, Fanous AH; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Bigdeli TB, et al. Am J Med Genet B Neuropsychiatr Genet. 2016 Mar;171B(2):276-89. doi: 10.1002/ajmg.b.32402. Epub 2015 Dec 11. Am J Med Genet B Neuropsychiatr Genet. 2016. PMID: 26663532 Free PMC article. - Association of Genetic Risk for Schizophrenia and Bipolar Disorder With Infant Neuromotor Development.
Serdarevic F, Jansen PR, Ghassabian A, White T, Jaddoe VWV, Posthuma D, Tiemeier H. Serdarevic F, et al. JAMA Psychiatry. 2018 Jan 1;75(1):96-98. doi: 10.1001/jamapsychiatry.2017.3459. JAMA Psychiatry. 2018. PMID: 29117282 Free PMC article. - The polygenic architecture of schizophrenia - rethinking pathogenesis and nosology.
Smeland OB, Frei O, Dale AM, Andreassen OA. Smeland OB, et al. Nat Rev Neurol. 2020 Jul;16(7):366-379. doi: 10.1038/s41582-020-0364-0. Epub 2020 Jun 11. Nat Rev Neurol. 2020. PMID: 32528109 Review. - The genetics of bipolar disorder.
Gordovez FJA, McMahon FJ. Gordovez FJA, et al. Mol Psychiatry. 2020 Mar;25(3):544-559. doi: 10.1038/s41380-019-0634-7. Epub 2020 Jan 6. Mol Psychiatry. 2020. PMID: 31907381 Review.
Cited by
- Optimizing and benchmarking polygenic risk scores with GWAS summary statistics.
Zhao Z, Gruenloh T, Yan M, Wu Y, Sun Z, Miao J, Wu Y, Song J, Lu Q. Zhao Z, et al. Genome Biol. 2024 Oct 8;25(1):260. doi: 10.1186/s13059-024-03400-w. Genome Biol. 2024. PMID: 39379999 Free PMC article. - The function of Mef2c toward the development of excitatory and inhibitory cortical neurons.
Ward C, Sjulson L, Batista-Brito R. Ward C, et al. Front Cell Neurosci. 2024 Sep 23;18:1465821. doi: 10.3389/fncel.2024.1465821. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39376213 Free PMC article. Review. - Genetic Diversity in Schizophrenia: Developmental Implications of Ultra-Rare, Protein-Truncating Mutations.
Clarin JD, Bouras NN, Gao WJ. Clarin JD, et al. Genes (Basel). 2024 Sep 17;15(9):1214. doi: 10.3390/genes15091214. Genes (Basel). 2024. PMID: 39336805 Free PMC article. Review. - A population-based study of familial coaggregation and shared genetic etiology of psychiatric and gastrointestinal disorders.
Pan YJ, Lin MC, Liou JM, Fan CC, Su MH, Chen CY, Wu CS, Chen PC, Huang YT, Wang SH. Pan YJ, et al. Commun Med (Lond). 2024 Sep 19;4(1):180. doi: 10.1038/s43856-024-00607-7. Commun Med (Lond). 2024. PMID: 39300237 Free PMC article. - Improving on polygenic scores across complex traits using select and shrink with summary statistics (S4) and LDpred2.
Tyrer JP, Peng PC, DeVries AA, Gayther SA, Jones MR, Pharoah PD. Tyrer JP, et al. BMC Genomics. 2024 Sep 18;25(1):878. doi: 10.1186/s12864-024-10706-3. BMC Genomics. 2024. PMID: 39294559 Free PMC article.
References
- Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet. 2000;97:12–17. - PubMed
- Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry. 2003;60:1187–1192. - PubMed
- O'Donovan MC, et al. Identification of loci associated with schizophrenia by genomewide association and follow-up. Nat Genet. 2008;40:1053–1055. - PubMed
- Wei J, Hemmings GP. The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat Genet. 2000;25:376–377. - PubMed
MeSH terms
Grants and funding
- R01 MH074027/MH/NIMH NIH HHS/United States
- G0500791/MRC_/Medical Research Council/United Kingdom
- R01 MH077139/MH/NIMH NIH HHS/United States
- G0800509/MRC_/Medical Research Council/United Kingdom
- R01 MH080403/MH/NIMH NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- P50 MH066392/MH/NIMH NIH HHS/United States
- 066717/WT_/Wellcome Trust/United Kingdom
- G0801418/MRC_/Medical Research Council/United Kingdom
- R01 MH071681/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical